Cargando…
Regenerative therapy by using mesenchymal stem cells-derived exosomes in COVID-19 treatment. The potential role and underlying mechanisms
COVID-19 disease caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), started in December 2019 in Wuhan, China, and quickly became the global pandemic. The high spread rate, relatively high mortality rate, and the lack of specific medicine have led researchers and clinicians w...
Autores principales: | Kaffash Farkhad, Najmeh, Mahmoudi, Ali, Mahdipour, Elahe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society for Regenerative Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938276/ https://www.ncbi.nlm.nih.gov/pubmed/35340407 http://dx.doi.org/10.1016/j.reth.2022.03.006 |
Ejemplares similares
-
Safety and efficacy of bone marrow derived-mesenchymal stem cells transplantation in patients with amyotrophic lateral sclerosis
por: Tavakol-Afshari, Jalil, et al.
Publicado: (2021) -
Mesenchymal Stem Cell-Derived Exosomes: Applications in Regenerative Medicine
por: Hade, Mangesh D., et al.
Publicado: (2021) -
Are mesenchymal stem cells able to manage cytokine storm in COVID-19 patients? A review of recent studies
por: Kaffash Farkhad, Najmeh, et al.
Publicado: (2021) -
Chromosomal Instability in Various Generations of Human Mesenchymal Stem Cells Following the Therapeutic Radiation
por: Sadeghi Moghadam, Majid, et al.
Publicado: (2023) -
Mesenchymal Stem Cell-Derived Exosomes as an Emerging Paradigm for Regenerative Therapy and Nano-Medicine: A Comprehensive Review
por: Panda, Biswajit, et al.
Publicado: (2021)